[1]D. S. Ridley and W. H. Jopling, “Classification of leprosy according to immunity. A five-group system,” International Journal of Leprosy and Other Mycobacterial Diseases, vol. 34, no.3, pp. 255–273, 1966.
[2] Zhang F, et a1. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet, 2011, 43:1247-51.
[3] Zhang FR, et al. Genomewide association study of leprosy. N Engl J Med, 2009,361: 2609-18.
[4] Geluk A, van Meijgaarden KE, Wilson L, et al. Longitudinal immune responses and gene expression profiles in type 1 leprosy reactions.J Clin Immunol, 2014,34(2):245-255.
[5] G. A. Hansen, “Baccilus leprae,” Norsk Mag Laegevidenskaben, vol. 9, pp. 1–21, 1874.
[6] Casanova J-L, Abel L. Genetic dissection of immunity to mycobacteria:The human model. Annu Rev Immunol, 2002, 20:581-620.
[7] Britton WJ, D.N.Lockwood. Leprosy. Lancent, 2004, 363:1209-1219.
[8] Ali PM , Ramanujam K . Leprosy in Tw ins . Int J Lepr , 1966 , 34: 404-407 .
[9] Fernando SL, Britton WJ. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol, 2006,84: 125-37.
[10] Ananthanarayanan M, Ng OC, Boyer JL, et a1. Characterization of cloned rat liver Nabile acid cotransporter using peptide and fusion protein antibodies. Am J Pysiol, 1994, 267(4Pt 1): G637一G643.
[11] Seyberth HW, Schlingmann KP. Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol. 2011;26(10):1789-802.
[12] Chen N, Tranebjærg L, Rendtorff ND, Schrijver I. Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting. J Mol Diagn. 2011;13(4):416-26.
[13] Sperandeo MP, Andria G, Sebastio G. Lysinuric protein intolerance: update and extended mutation analysis of the SLC7A7 gene. Hum Mutat. 2008;29(1):14-21.
[14] Qiu ZQ, Lu CX, Wang W, Qiu JJ, Wei M. [Mutation in the SLC37A4 gene of glycogen storage disease type Ib in 15 families of the mainland of China]. Zhonghua Er Ke Za Zhi. 2011;49(3):203-8.
[15] Choi R, Park HD, Ko JM, et al. Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib. Ann Lab Med. 2017;37(3):261-266.
[16] Carlin MP, Scherrer DZ, De tommaso AM, Bertuzzo CS, Steiner CE. Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib. Genet Mol Biol. 2013;36(4):502-6.
[17] Chen SR, Yang LQ, Chong YT, et al. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4. Intern Med J. 2015;45(6):672-6.
[18] Cook AL, Chen W, Thurber AE, Smit DJ, Smith AG, Bladen TG, et al. Analysis of cultured human melanocytes based on polymorphisms within SLC24A2/MATP, SLC24A2/NCKX5, and OCA2/P loci. J Invest Dermatol. 2008; 129(2):392-405
[19] Song Z. Roles of the nucleotide sugar transporters (SLC35 family) in health and disease. Mol Aspects Med. 2013;34(2-3):590-600.
[20] Sarangi A, Bupp K, Roth MJ. Identification of a retroviral receptor used by an envelope protein derived by peptide library screening. Proc Natl Acad Sci USA. 2007;104(26):11032-7.
[21] Schlessinger A, Matsson P, Shima JE, et al. Comparison of human solute carriers. Protein Sci. 2010;19(3):412-28.
[22] Orentas RJ, Yang JJ, Wen X, Wei JS, Mackall CL, Khan J. Identification of cell surface proteins as potential immunotherapy targets in 12 pediatric cancers. Front Oncol. 2012;2:194.
[23] Ishida N, Kawakita M. Molecular physiology and pathology of the nucleotide sugar transporter family (SLC35). Pflugers Arch. 2004;447(5):768-75.
[24] Mira MT, Alcaïs A, Nguyen VT, et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature. 2004;427(6975):636-40.
[25] Wang Z, Sun Y, Fu X, et al. A large-scale genome-wide association and meta-analysis identified four novel susceptibility loci for leprosy. Nat Commun. 2016;7:13760.
[26] Liu H, Irwanto A, Tian H, et al. Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases. Am J Hum Genet. 2012;91(5):935-41.
[27] Fava VM, Manry J, Cobat A, et al. A genome wide association study identifies a lncRna as risk factor for pathological inflammatory responses in leprosy. PLoS Genet. 2017;13(2):e1006637.
[28] Jarduli LR, Sell AM, Reis PG, et al. Role of HLA, KIR, MICA, and cytokines genes in leprosy. Biomed Res Int. 2013;2013:989837.
[29] Koriyama H, Nakagami H, Katsuya T, et al. Identification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population. J Atheroscler Thromb. 2010;17(10):1054-62.
[30] Li H, Wetten S, Li L, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol. 2008;65(1):45-53.
[31] Sierra B, Triska P, Soares P, et al. OSBPL10, RXRA and lipid metabolism confer African-ancestry protection against dengue haemorrhagic fever in admixed Cubans. PLoS Pathog. 2017;13(2):e1006220.
[32] Blackwell JM, Goswami T, Evans CA, et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 2001;3(12):773-84.
[33] Meilang Q, Zhang Y, Zhang J, et al. Polymorphisms in the SLC11A1 gene and tuberculosis risk: a meta-analysis update. Int J Tuberc Lung Dis. 2012;16(4):437-46.
[34] Ates O, Dalyan L, Müsellim B, et al. NRAMP1 (SLC11A1) gene polymorphisms that correlate with autoimmune versus infectious disease susceptibility in tuberculosis and rheumatoid arthritis. Int J Immunogenet. 2009;36(1):15-9.
[35] Brochado MJ, Gatti MF, Zago MA, Roselino AM. Association of the solute carrier family 11 member 1 gene polymorphisms with susceptibility to leprosy in a Brazilian sample. Mem Inst Oswaldo Cruz. 2016;111(2):101-5.
[36] Niño-moreno P, Turrubiartes-martínez E, Oceguera-maldonado B, et al. The Role of NRAMP1/SLC11A1 Gene Variant D543N (1730G/A) in the Genetic Susceptibility to Develop Rheumatoid Arthritis in the Mexican Mestizo population. Rev Invest Clin. 2017;69(1):5-10.
[37] Chermesh I, Azriel A, Alter-koltunoff M, Eliakim R, Karban A, Levi BZ. Crohn's disease and SLC11A1 promoter polymorphism. Dig Dis Sci. 2007;52(7):1632-5.
[38] Sechi LA, Gazouli M, Sieswerda LE, et al. Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol. 2006;12(44):7161-4.
[39] Zheng W, Rosenstiel P, Huse K, et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 2006;7(1):11-8.